Global Multi-disease Fundus Imaging-assisted Diagnostic System Market 2026 by Company, Regions, Type and Application, Forecast to 2032

July 2026 | 130 pages | ID: G3D20C672012EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Multi-disease Fundus Imaging-assisted Diagnostic System market size was valued at US$ 1919 million in 2025 and is forecast to a readjusted size of US$ 3344 million by 2032 with a CAGR of 8.3% during review period.

A multi-disease fundus imaging-assisted diagnostic system is a medical assistance system based on medical image processing, artificial intelligence algorithms, and fundus imaging technology. It automatically analyzes multimodal images such as fundus color photographs and OCT scans to screen, classify, and assist in the diagnosis of various fundus and systemic diseases, thereby helping doctors improve diagnostic efficiency and accuracy.

With the continuous rise in the prevalence of diabetes, age-related eye diseases, and chronic diseases, and the increasing demand for early screening and diagnosis in primary healthcare, multi-disease fundus imaging-assisted diagnostic systems are becoming one of the fastest-growing areas in the field of AI medical imaging. In the future, driven by deep learning models in artificial intelligence, multimodal image fusion, and large-scale clinical data training, its diagnostic capabilities will continuously approach or even surpass the level of junior ophthalmologists in some screening scenarios, and will be widely applied in primary healthcare screening, telemedicine, health checkups, and chronic disease management systems.

This report is a detailed and comprehensive analysis for global Multi-disease Fundus Imaging-assisted Diagnostic System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Multi-disease Fundus Imaging-assisted Diagnostic System market size and forecasts, in consumption value ($ Million), 2021-2032

Global Multi-disease Fundus Imaging-assisted Diagnostic System market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Multi-disease Fundus Imaging-assisted Diagnostic System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Multi-disease Fundus Imaging-assisted Diagnostic System market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:
  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Multi-disease Fundus Imaging-assisted Diagnostic System
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Multi-disease Fundus Imaging-assisted Diagnostic System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AEYE Health, RetinaLyze, DeepMind, Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Intelligent Retinal Imaging Systems, Retmarker, CSIRO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Multi-disease Fundus Imaging-assisted Diagnostic System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • On-premise
  • Cloud-based
Market segment by Technology/Imaging Fundamentals
  • AI Based on Fundus Images
  • AI Based on OCT
Market segment by Disease Levels
  • Retinal Vascular Diseases
  • Macular Diseases
  • Optical Nerve Diseases
  • Others
Market segment by Application
  • Hospitals
  • Clinics
Market segment by players, this report covers
  • AEYE Health
  • RetinaLyze
  • DeepMind
  • Remidio
  • RetinAI
  • RetinaRisk
  • Eyenuk, Inc.
  • Intelligent Retinal Imaging Systems
  • Retmarker
  • CSIRO
  • WeDoctor Group
  • VoxelCloud
  • Zhenhealth
  • Tencent Health
  • Airdoc
  • Silicon Intelligence
  • Zhiyuan Huitu
  • Kangfuzi Health
Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Multi-disease Fundus Imaging-assisted Diagnostic System product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Multi-disease Fundus Imaging-assisted Diagnostic System, with revenue, gross margin, and global market share of Multi-disease Fundus Imaging-assisted Diagnostic System from 2021 to 2026.

Chapter 3, the Multi-disease Fundus Imaging-assisted Diagnostic System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Multi-disease Fundus Imaging-assisted Diagnostic System market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Multi-disease Fundus Imaging-assisted Diagnostic System.

Chapter 13, to describe Multi-disease Fundus Imaging-assisted Diagnostic System research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Multi-disease Fundus Imaging-assisted Diagnostic System by Type
  1.3.1 Overview: Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Type in 2025
  1.3.3 On-premise
  1.3.4 Cloud-based
1.4 Classification of Multi-disease Fundus Imaging-assisted Diagnostic System by Technology/Imaging Fundamentals
  1.4.1 Overview: Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Technology/Imaging Fundamentals: 2021 Versus 2025 Versus 2032
  1.4.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Technology/Imaging Fundamentals in 2025
  1.4.3 AI Based on Fundus Images
  1.4.4 AI Based on OCT
1.5 Classification of Multi-disease Fundus Imaging-assisted Diagnostic System by Disease Levels
  1.5.1 Overview: Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Disease Levels: 2021 Versus 2025 Versus 2032
  1.5.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Disease Levels in 2025
  1.5.3 Retinal Vascular Diseases
  1.5.4 Macular Diseases
  1.5.5 Optical Nerve Diseases
  1.5.6 Others
1.6 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market by Application
  1.6.1 Overview: Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Hospitals
  1.6.3 Clinics
1.7 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size & Forecast
1.8 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast by Region
  1.8.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region: 2021 VS 2025 VS 2032
  1.8.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region, (2021-2032)
  1.8.3 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Prospect (2021-2032)
  1.8.4 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Prospect (2021-2032)
  1.8.5 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Prospect (2021-2032)
  1.8.6 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Prospect (2021-2032)
  1.8.7 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 AEYE Health
  2.1.1 AEYE Health Details
  2.1.2 AEYE Health Major Business
  2.1.3 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.1.4 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 AEYE Health Recent Developments and Future Plans
2.2 RetinaLyze
  2.2.1 RetinaLyze Details
  2.2.2 RetinaLyze Major Business
  2.2.3 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.2.4 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 RetinaLyze Recent Developments and Future Plans
2.3 DeepMind
  2.3.1 DeepMind Details
  2.3.2 DeepMind Major Business
  2.3.3 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.3.4 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 DeepMind Recent Developments and Future Plans
2.4 Remidio
  2.4.1 Remidio Details
  2.4.2 Remidio Major Business
  2.4.3 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.4.4 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Remidio Recent Developments and Future Plans
2.5 RetinAI
  2.5.1 RetinAI Details
  2.5.2 RetinAI Major Business
  2.5.3 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.5.4 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 RetinAI Recent Developments and Future Plans
2.6 RetinaRisk
  2.6.1 RetinaRisk Details
  2.6.2 RetinaRisk Major Business
  2.6.3 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.6.4 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 RetinaRisk Recent Developments and Future Plans
2.7 Eyenuk, Inc.
  2.7.1 Eyenuk, Inc. Details
  2.7.2 Eyenuk, Inc. Major Business
  2.7.3 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.7.4 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Eyenuk, Inc. Recent Developments and Future Plans
2.8 Intelligent Retinal Imaging Systems
  2.8.1 Intelligent Retinal Imaging Systems Details
  2.8.2 Intelligent Retinal Imaging Systems Major Business
  2.8.3 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.8.4 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 Intelligent Retinal Imaging Systems Recent Developments and Future Plans
2.9 Retmarker
  2.9.1 Retmarker Details
  2.9.2 Retmarker Major Business
  2.9.3 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.9.4 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Retmarker Recent Developments and Future Plans
2.10 CSIRO
  2.10.1 CSIRO Details
  2.10.2 CSIRO Major Business
  2.10.3 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.10.4 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 CSIRO Recent Developments and Future Plans
2.11 WeDoctor Group
  2.11.1 WeDoctor Group Details
  2.11.2 WeDoctor Group Major Business
  2.11.3 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.11.4 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 WeDoctor Group Recent Developments and Future Plans
2.12 VoxelCloud
  2.12.1 VoxelCloud Details
  2.12.2 VoxelCloud Major Business
  2.12.3 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.12.4 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 VoxelCloud Recent Developments and Future Plans
2.13 Zhenhealth
  2.13.1 Zhenhealth Details
  2.13.2 Zhenhealth Major Business
  2.13.3 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.13.4 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Zhenhealth Recent Developments and Future Plans
2.14 Tencent Health
  2.14.1 Tencent Health Details
  2.14.2 Tencent Health Major Business
  2.14.3 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.14.4 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 Tencent Health Recent Developments and Future Plans
2.15 Airdoc
  2.15.1 Airdoc Details
  2.15.2 Airdoc Major Business
  2.15.3 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.15.4 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 Airdoc Recent Developments and Future Plans
2.16 Silicon Intelligence
  2.16.1 Silicon Intelligence Details
  2.16.2 Silicon Intelligence Major Business
  2.16.3 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.16.4 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.16.5 Silicon Intelligence Recent Developments and Future Plans
2.17 Zhiyuan Huitu
  2.17.1 Zhiyuan Huitu Details
  2.17.2 Zhiyuan Huitu Major Business
  2.17.3 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.17.4 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.17.5 Zhiyuan Huitu Recent Developments and Future Plans
2.18 Kangfuzi Health
  2.18.1 Kangfuzi Health Details
  2.18.2 Kangfuzi Health Major Business
  2.18.3 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
  2.18.4 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Gross Margin and Market Share (2021-2026)
  2.18.5 Kangfuzi Health Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Multi-disease Fundus Imaging-assisted Diagnostic System by Company Revenue
  3.2.2 Top 3 Multi-disease Fundus Imaging-assisted Diagnostic System Players Market Share in 2025
  3.2.3 Top 6 Multi-disease Fundus Imaging-assisted Diagnostic System Players Market Share in 2025
3.3 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Overall Company Footprint Analysis
  3.3.1 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Region Footprint
  3.3.2 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Type Footprint
  3.3.3 Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value and Market Share by Type (2021-2026)
4.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Application (2021-2026)
5.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2032)
6.2 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021-2032)
6.3 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country
  6.3.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2021-2032)
  6.3.2 United States Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  6.3.3 Canada Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  6.3.4 Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2032)
7.2 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2032)
7.3 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country
  7.3.1 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2021-2032)
  7.3.2 Germany Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  7.3.3 France Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  7.3.5 Russia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  7.3.6 Italy Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region
  8.3.1 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2021-2032)
  8.3.2 China Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  8.3.3 Japan Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  8.3.4 South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  8.3.5 India Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  8.3.7 Australia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2032)
9.2 South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2032)
9.3 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country
  9.3.1 South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2021-2032)
  9.3.2 Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  9.3.3 Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country
  10.3.1 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2021-2032)
  10.3.2 Turkey Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)
  10.3.4 UAE Multi-disease Fundus Imaging-assisted Diagnostic System Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers
11.2 Multi-disease Fundus Imaging-assisted Diagnostic System Market Restraints
11.3 Multi-disease Fundus Imaging-assisted Diagnostic System Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Chain
12.2 Multi-disease Fundus Imaging-assisted Diagnostic System Upstream Analysis
12.3 Multi-disease Fundus Imaging-assisted Diagnostic System Midstream Analysis
12.4 Multi-disease Fundus Imaging-assisted Diagnostic System Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer


LIST OF TABLES

Table 1. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Technology/Imaging Fundamentals, (USD Million), 2021 & 2025 & 2032
Table 3. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Disease Levels, (USD Million), 2021 & 2025 & 2032
Table 4. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2027-2032) & (USD Million)
Table 7. AEYE Health Company Information, Head Office, and Major Competitors
Table 8. AEYE Health Major Business
Table 9. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 10. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. AEYE Health Recent Developments and Future Plans
Table 12. RetinaLyze Company Information, Head Office, and Major Competitors
Table 13. RetinaLyze Major Business
Table 14. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 15. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. RetinaLyze Recent Developments and Future Plans
Table 17. DeepMind Company Information, Head Office, and Major Competitors
Table 18. DeepMind Major Business
Table 19. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 20. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Remidio Company Information, Head Office, and Major Competitors
Table 22. Remidio Major Business
Table 23. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 24. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Remidio Recent Developments and Future Plans
Table 26. RetinAI Company Information, Head Office, and Major Competitors
Table 27. RetinAI Major Business
Table 28. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 29. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. RetinAI Recent Developments and Future Plans
Table 31. RetinaRisk Company Information, Head Office, and Major Competitors
Table 32. RetinaRisk Major Business
Table 33. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 34. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. RetinaRisk Recent Developments and Future Plans
Table 36. Eyenuk, Inc. Company Information, Head Office, and Major Competitors
Table 37. Eyenuk, Inc. Major Business
Table 38. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 39. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Eyenuk, Inc. Recent Developments and Future Plans
Table 41. Intelligent Retinal Imaging Systems Company Information, Head Office, and Major Competitors
Table 42. Intelligent Retinal Imaging Systems Major Business
Table 43. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 44. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Intelligent Retinal Imaging Systems Recent Developments and Future Plans
Table 46. Retmarker Company Information, Head Office, and Major Competitors
Table 47. Retmarker Major Business
Table 48. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 49. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Retmarker Recent Developments and Future Plans
Table 51. CSIRO Company Information, Head Office, and Major Competitors
Table 52. CSIRO Major Business
Table 53. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 54. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. CSIRO Recent Developments and Future Plans
Table 56. WeDoctor Group Company Information, Head Office, and Major Competitors
Table 57. WeDoctor Group Major Business
Table 58. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 59. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. WeDoctor Group Recent Developments and Future Plans
Table 61. VoxelCloud Company Information, Head Office, and Major Competitors
Table 62. VoxelCloud Major Business
Table 63. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 64. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. VoxelCloud Recent Developments and Future Plans
Table 66. Zhenhealth Company Information, Head Office, and Major Competitors
Table 67. Zhenhealth Major Business
Table 68. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 69. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Zhenhealth Recent Developments and Future Plans
Table 71. Tencent Health Company Information, Head Office, and Major Competitors
Table 72. Tencent Health Major Business
Table 73. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 74. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Tencent Health Recent Developments and Future Plans
Table 76. Airdoc Company Information, Head Office, and Major Competitors
Table 77. Airdoc Major Business
Table 78. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 79. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Airdoc Recent Developments and Future Plans
Table 81. Silicon Intelligence Company Information, Head Office, and Major Competitors
Table 82. Silicon Intelligence Major Business
Table 83. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 84. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Silicon Intelligence Recent Developments and Future Plans
Table 86. Zhiyuan Huitu Company Information, Head Office, and Major Competitors
Table 87. Zhiyuan Huitu Major Business
Table 88. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 89. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Zhiyuan Huitu Recent Developments and Future Plans
Table 91. Kangfuzi Health Company Information, Head Office, and Major Competitors
Table 92. Kangfuzi Health Major Business
Table 93. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product and Solutions
Table 94. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Kangfuzi Health Recent Developments and Future Plans
Table 96. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (USD Million) by Players (2021-2026)
Table 97. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Share by Players (2021-2026)
Table 98. Breakdown of Multi-disease Fundus Imaging-assisted Diagnostic System by Company Type (Tier 1, Tier 2, and Tier 3)
Table 99. Market Position of Players in Multi-disease Fundus Imaging-assisted Diagnostic System, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office of Key Multi-disease Fundus Imaging-assisted Diagnostic System Players
Table 101. Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Type Footprint
Table 102. Multi-disease Fundus Imaging-assisted Diagnostic System Market: Company Product Application Footprint
Table 103. Multi-disease Fundus Imaging-assisted Diagnostic System New Market Entrants and Barriers to Market Entry
Table 104. Multi-disease Fundus Imaging-assisted Diagnostic System Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (USD Million) by Type (2021-2026)
Table 106. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Share by Type (2021-2026)
Table 107. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Forecast by Type (2027-2032)
Table 108. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2026)
Table 109. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Forecast by Application (2027-2032)
Table 110. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2026) & (USD Million)
Table 111. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2027-2032) & (USD Million)
Table 112. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2026) & (USD Million)
Table 113. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2027-2032) & (USD Million)
Table 114. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2027-2032) & (USD Million)
Table 124. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2027-2032) & (USD Million)
Table 126. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2021-2026) & (USD Million)
Table 127. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Region (2027-2032) & (USD Million)
Table 128. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2026) & (USD Million)
Table 129. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2027-2032) & (USD Million)
Table 130. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2026) & (USD Million)
Table 131. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2027-2032) & (USD Million)
Table 132. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type (2027-2032) & (USD Million)
Table 136. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application (2027-2032) & (USD Million)
Table 138. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System Upstream (Raw Materials)
Table 141. Global Multi-disease Fundus Imaging-assisted Diagnostic System Typical Customers

LIST OF FIGURES

Figure 1. Multi-disease Fundus Imaging-assisted Diagnostic System Picture
Figure 2. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Type in 2025
Figure 4. On-premise
Figure 5. Cloud-based
Figure 6. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Technology/Imaging Fundamentals, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Technology/Imaging Fundamentals in 2025
Figure 8. AI Based on Fundus Images
Figure 9. AI Based on OCT
Figure 10. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Disease Levels, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Disease Levels in 2025
Figure 12. Retinal Vascular Diseases
Figure 13. Macular Diseases
Figure 14. Optical Nerve Diseases
Figure 15. Others
Figure 16. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Application in 2025
Figure 18. Hospitals Picture
Figure 19. Clinics Picture
Figure 20. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Market Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 23. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Region (2021-2032)
Figure 24. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Region in 2025
Figure 25. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 26. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 27. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 28. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 29. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 30. Company Three Recent Developments and Future Plans
Figure 31. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Share by Players in 2025
Figure 32. Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 33. Market Share of Multi-disease Fundus Imaging-assisted Diagnostic System by Player Revenue in 2025
Figure 34. Top 3 Multi-disease Fundus Imaging-assisted Diagnostic System Players Market Share in 2025
Figure 35. Top 6 Multi-disease Fundus Imaging-assisted Diagnostic System Players Market Share in 2025
Figure 36. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Share by Type (2021-2026)
Figure 37. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share Forecast by Type (2027-2032)
Figure 38. Global Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Share by Application (2021-2026)
Figure 39. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share Forecast by Application (2027-2032)
Figure 40. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Type (2021-2032)
Figure 41. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Application (2021-2032)
Figure 42. North America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Country (2021-2032)
Figure 43. United States Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 44. Canada Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 45. Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Type (2021-2032)
Figure 47. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Application (2021-2032)
Figure 48. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 50. France Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Region (2021-2032)
Figure 57. China Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 58. Japan Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 59. South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 60. India Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 61. Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 62. Australia Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 63. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Type (2021-2032)
Figure 64. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Application (2021-2032)
Figure 65. South America Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Country (2021-2032)
Figure 66. Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 67. Argentina Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 68. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Type (2021-2032)
Figure 69. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Application (2021-2032)
Figure 70. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 73. UAE Multi-disease Fundus Imaging-assisted Diagnostic System Consumption Value (2021-2032) & (USD Million)
Figure 74. Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers
Figure 75. Multi-disease Fundus Imaging-assisted Diagnostic System Market Restraints
Figure 76. Multi-disease Fundus Imaging-assisted Diagnostic System Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Multi-disease Fundus Imaging-assisted Diagnostic System Industrial Chain
Figure 79. Methodology
Figure 80. Research Process and Data Source


More Publications